• SENSEX 81,583.30
    -212.85 (--0.26%)
  • BANKNIFTY 55,714.15
    -230.75 (--0.41%)
  • Vishal Mega Mart
    129.95 134.50(%)
  • Reliance Industr
    1,425.80 1,115.55(%)
  • Infosys
    1,647.70 2,006.80(%)
  • Sterlite Tech.
    119.00 109.09(%)
  • HDFC Bank
    1,919.55 1,588.50(%)
  • Varun Beverages
    469.50 419.40(%)
  • ICICI Bank
    1,417.60 1,101.00(%)
  • TCS
    3,522.30 4,585.90(%)
  • Happiest Minds
    674.00 955.00(%)
  • Mazagon Dock
    3,342.85 3,778.00(%)
  • Garden Reach Sh.
    3,205.00 3,528.00(%)
  • Bharti Airtel
    1,847.50 1,373.05(%)
  • M & M
    2,993.70 2,360.45(%)
  • Kotak Mah. Bank
    2,129.90 1,679.10(%)
  • Tata Motors
    672.00 542.55(%)
  • Cochin Shipyard
    2,244.10 2,977.10(%)
  • Hind. Unilever
    2,334.10 3,034.50(%)
  • Sun Pharma.Inds.
    1,641.40 1,461.40(%)
  • St Bk of India
    790.75 679.65(%)
  • HCL Technologies
    1,738.00 2,011.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biofil Chemicals & Pharmaceuticals Ltd Pharmaceuticals - Indian - Formulations

  • Systematix
  • BSE Code : 3284.0
  • ISIN : INE829A01014
48.93 -1 (-2.18%)
  • As on 17 Jun 2025 (EOD)

  • Today’s Low

    48.00

  • Today’s High

    50.02

  • Open

    50.02

  • Perv Close

    50.02

  • 52W Low

    40.40

  • 52W High

    91.87

Key Indicators

  • P/E(TTM)

    148.56

  • Mar.Cap (₹Cr.)

    79.61

  • Div & Yield %

    0.00

  • Book Value(₹)

    11.54

  • Debt-Equity Ratio

    -2.18

  • AGM Date

    17-Jun-2025

  • EPS

    0.34

  • P/E Ratio

    148.56

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    79.61

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    16.27

  • BV (₹)

    11.50

  • Sales( ₹ in Cr.)

    33.40

  • NP (in Cr.)

    0.56

  • NP Var(%)

    -21.0

  • Div%

    0.0

  • CPS (₹)

    0.60

  • EPS (₹)

    0.30

  • Traded Value (₹ in Lakhs)

    81.14

  • 52 Week High

    91.87

  • 52 Week Low

    40.40

  • Price BSE

    50.0

  • Price NSE

    50.00

  • Market Capital( in Cr.)

    81.14

  • P/C Ratio

    86.80

  • P/E Ratio

    145.80

  • Price Vs.BV

    0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 40.04 30.04 22.38 35.75 29.69 23.13
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 40.04 30.04 22.38 35.75 29.69 23.13
Other Income 0.49 0.10 0.15 0.80 0.17 0.10
Stock Adjustments 0.27 0.20 -3.59 2.77 0.34 -0.17
Total Income 40.80 30.34 18.94 39.32 30.20 23.06
EXPENDITURE :            
Raw Materials 37.78 27.62 15.87 35.20 25.65 19.82
Power and Fuel Cost 0.38 0.33 0.30 0.29 0.49 0.37
Employee Cost 0.50 0.45 0.79 0.75 0.86 0.89
Other Manufacturing Expenses 0.17 0.05 0.09 0.23 0.40 0.11
Selling and Administration Expenses 0.56 0.54 0.37 0.37 0.78 0.72
Miscellaneous Expenses 0.11 0.08 0.05 0.08 0.03 0.02
Employee Benefit Expenses 0.50 0.45 0.79 0.75 0.86 0.89
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 39.49 29.06 17.46 36.92 28.21 21.93
Operating Profit 1.30 1.26 1.48 2.40 1.99 1.12
Interest 0.04 0.04 0.04 0.07 0.12 0.16
Gross Profit 1.26 1.22 1.44 2.33 1.87 0.96
Depreciation 0.40 0.43 0.43 0.41 0.41 0.37
Profit Before Tax 0.86 0.79 1.01 1.92 1.46 0.59
Current Tax 0.24 0.22 0.28 0.32 0.26 0.12
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.09 0.01 0.04 0.35 0.00 0.00
Reported Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.71 0.56 0.70 1.24 1.21 0.48
Adjustment below Net Profit 0.19 -0.10 0.04 0.00 0.03 0.00
P & L Balance brought forward -32.60 -33.06 -33.79 -35.01 -36.25 -36.73
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -31.69 -32.60 -33.06 -33.77 -35.01 -36.25
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.44 0.34 0.43 0.76 0.74 0.30
Earnings Per Share(Adj)-Unit Curr 0.44 0.34 0.43 0.76 0.74 0.30
Book Value 11.19 10.63 10.35 9.91 9.15 8.39
Book Value(Adj)-Unit Curr 11.19 10.63 10.35 9.91 9.15 8.39

Shareholding Pattern

  • Promoter Group

    46.82%

  • Public Share Holding

    53.18%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,314,200 26.51 4,314,200 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,304,560 20.31 3,304,560 13
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 7,618,760 46.82 7,618,760 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 6,200 0.04 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 135 0.00 135 1
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 7,000 0.04 0 3
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 13,335 0.08 135 5
2] Non Institution
Bodies Corporate 2,010,784 12.36 1,914,084 79
Clearing Members 3,586 0.02 3,586 6
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 65,800 0.40 0 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 195,012 1.20 112,312 294
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 132,304 0.81 132,304 180
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 634,792 3.90 634,792 11
Individuals holding nominal share capital up to Rs. 1 lakh 5,599,327 34.41 5,003,727 25,321
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 100 0.00 0 1
Others 0 0.00 0 0
Sub Total 8,641,705 53.10 7,800,805 25,893
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 16,273,800 100.00 15,419,700 25,914

Company Background

Biofil Chemicals & Pharmaceuticals LtdPharmaceuticals - Indian - Formulations

  • Biofil Chemicals & Pharmaceuticals Ltd
  • BSE Code : 3284.0
  • ISIN : INE829A01014

  • Incorporation Year

    1985

  • Registered Office

    11/12 Sector E Sanwer Road
    Sanwer Road Industrial Area, Indore,
    Madhya Pradesh-452015

  • Telephone

    91-731-2426700

  • FAX

    91-731-2420926

  • Chairman

    Ramesh Shah

  • Managing Director

    Ramesh Shah

  • Company Secretary

  • Auditor

    Maheshwari & Gupta

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Ankit Consultancy Pvt Ltd
    Plot No. 60,
    Electronic Complex,Pardeshipura
    Mumbai - Indore - 452010

Biofil Chemicals & Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biofil Chemicals 50.51 40.53 40.04 148.56 1.81
Abbott India 31,803.35 6,097.18 5,848.91 47.78 44.71
Astrazeneca Phar 10,081.60 1,330.33 1,295.53 217.75 33.26
P & G Health Ltd 5,907.05 1,166.89 1,151.26 39.04 39.76
Glaxosmi. Pharma 3,252.30 3,866.05 3,723.49 59.95 58.72
Cipla 1,503.50 17,645.00 16,574.34 23.54 20.10
Amrutanjan Healt 708.25 437.58 421.23 40.29 20.84
Guj. Themis Bio. 337.05 174.19 169.82 75.23 44.82
Fermenta Biotec. 334.25 315.24 307.09 14.55 4.10
Bliss GVS Pharma 141.95 638.96 605.46 21.67 11.19
Ambalal Sarabhai 36.76 11.70 3.81 34.04 1.92